Tissue concentration of systemically administered antineoplastic agents in human brain tumors

le Pitz, Marshall W., Desai, Arati, Grossman, Stuart A., Blakeley, Jaishri O.
Foilsithe 2011

PATH-25. EXPERIENCE WITH AN RNA FUSION TRANSCRIPT PANEL FOR DETECTION OF POTENTIAL THERAPEUTIC TARGETS IN GLIOMAS

le Kothari, Shawn, Bagley, Stephen, Desai, Arati, Morrisette, Jennifer, Sussman, Robyn, MacLean, Nasrallah
Foilsithe in Neuro Oncol (2020)

PATH-02. USE OF RNAseq TO IDENTIFY TUMOR CELL AND MICROENVIRONMENT FACTORS ASSOCIATED WITH IMMUNE CYTOLYTIC ACTIVITY IN GLIOBLASTOMA

le Bagley, Stephen J, O’Rourke, Donald M, Brem, Steven, Linette, Gerald P, Desai, Arati S
Foilsithe in Neuro Oncol (2017)

Multiparametric MRI assessment of response to convection-enhanced intratumoral delivery of MDNA55, an interleukin-4 receptor targeted immunotherapy, for recurrent glioblastoma

le Mohan, Suyash, Wang, Sumei, Chawla, Sanjeev, Abdullah, Kalil, Desai, Arati, Maloney, Eileen, Brem, Steven
Foilsithe in Surg Neurol Int (2021)

Obesity, Mammography Use and Accuracy, and Advanced Breast Cancer Risk

le Kerlikowske, Karla, Walker, Rod, Miglioretti, Diana L., Desai, Arati, Ballard-Barbash, Rachel, Buist, Diana S. M.
Foilsithe 2008

CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges

le Bagley, Stephen J, Desai, Arati S, Linette, Gerald P, June, Carl H, O’Rourke, Donald M
Foilsithe in Neuro Oncol (2018)

Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck

le BAUMAN, JESSICA, LANGER, COREY, QUON, HARRY, ALGAZY, KENNETH, LIN, ALEXANDER, DESAI, ARATI, MUTALE, FAITH, WEISS, JARED
Foilsithe 2013

PATH-41. PLASMA CELL-FREE DNA (cfDNA) CONCENTRATION IS INDEPENDENTLY ASSOCIATED WITH RADIOGRAPHIC TUMOR BURDEN IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PRIOR TO INITIAL SURGICAL RESEC...

le Bagley, Stephen, Till, Jacob, Mays, Jazmine, Nabavizadeh, Seyed, Yee, Stephanie, Levy, Scott, Desai, Arati, Carpenter, Erica
Foilsithe in Neuro Oncol (2018)

A dual-genotype oligoastrocytoma with histologic, molecular, radiological and time-course features

le Nasrallah, Mac Lean P., Desai, Arati, O’Rourke, Donald M., Surrey, Lea F., Stein, Joel M.
Foilsithe in Acta Neuropathol Commun (2020)

PATH-40. TARGETED NEXT GENERATION SEQUENCING (NGS) OF YOUNG ADULTS WITH ISOCITRATE-DEHYDROGENASE WILD-TYPE GLIOBLASTOMA (IDH-WT GBM) REVEALS NEGATIVE PROGNOSTIC IMPACT OF EPIDERMAL...

le Hoffman, Daniel, Abdullah, Kalil, Binder, Zev, O’Rourke, Donald, Desai, Arati, Morrissette, Jennifer, Brem, Steven, Bagley, Stephen
Foilsithe in Neuro Oncol (2018)

RNA-seq for identification of therapeutically targetable determinants of immune activation in human glioblastoma

le Bagley, Stephen J., Hwang, Wei-Ting, Brem, Steven, Linette, Gerald P., O’Rourke, Donald M., Desai, Arati S.
Foilsithe in J Neurooncol (2018)

2137 Percentage of viable tumor Versus radiation treatment effect in surgical specimens is not associated with outcomes in recurrent glioblastoma

le Schwab, Robert D., Bagley, Stephen, Binder, Zev, Lustig, Robert, O’Rourke, Donald, Brem, Steven, Desai, Arati S., Nasrallah, MacLean
Foilsithe in J Clin Transl Sci (2018)

RBTT-05. A SINGLE-ARM, OPEN-LABEL, PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF ABEMACICLIB IN PATIENTS WITH RECURRENT OLIGODENDROGLIOMA: TRIALS IN PROGRESS

le Bagley, Stephen, Nasrallah, MacLean, O’Rourke, Donald, Hussain, Jasmin, Maloney-Wilensky, Eileen, Prior, Timothy, Brem, Steven, Desai, Arati
Foilsithe in Neuro Oncol (2019)

RBTT-12. A PHASE I STUDY OF EGFRVIII-DIRECTED CAR T CELLS COMBINED WITH PD-1 INHIBITION IN PATIENTS WITH NEWLY, DIAGNOSED, MGMT-UNMETHYLATED GLIOBLASTOMA: TRIAL IN PROGRESS

le Bagley, Stephen, Desai, Arati, Binder, Zev, Nasrallah, MacLean, Hwang, Wei-Ting, Maloney-Wilensky, Eileen, Prior, Timothy, Brem, Steven, O’Rourke, Donald
Foilsithe in Neuro Oncol (2019)

ACTR-15. SAFETY AND PRELIMINARY ACTIVITY OF PT2385, A FIRST-IN-CLASS HIF2-ALPHA INHIBITOR, PLANNED INTERIM ANALYSIS OF AN OPEN LABEL, SINGLE-ARM PHASE II STUDY IN PATIENTS WITH REC...

le Strowd, Roy, Ellingson, Benjamin, Wen, Patrick, Ahluwalia, Manmeet, Piotrowski, Anna, Desai, Arati, Clarke, Jennifer, Lieberman, Frank, Desideri, Serena, Nabors, L Burt, Grossman, Stuart
Foilsithe in Neuro Oncol (2018)

Microvesicles as a Biomarker for Tumor Progression versus Treatment Effect in Radiation/Temozolomide-Treated Glioblastoma Patients

le Koch, Cameron J., Lustig, Robert A., Yang, Xiang-Yang, Jenkins, Walter T., Wolf, Ronald L., Martinez-Lage, Maria, Desai, Arati, Williams, Dewight, Evans, Sydney M.
Foilsithe in Transl Oncol (2014)

Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients

le Evans, Sydney M., Putt, Mary, Yang, Xiang-Yang, Lustig, Robert A., Martinez-Lage, Maria, Williams, Dewight, Desai, Arati, Wolf, Ronald, Brem, Steven, Koch, Cameron J.
Foilsithe in J Neurooncol (2016)

ATIM-21. UPDATED RESULTS OF A PHASE I TRIAL OF ANTI-LAG-3 OR ANTI-CD137 ALONE AND IN COMBINATION WITH ANTI-PD-1 IN PATIENTS WITH RECURRENT GBM

le Lim, Michael, Ye, Xiaobu, Nabors, L Burt, Piotrowski, Anna, Ahluwalia, Manmeet, Desai, Arati, Walbert, Tobias, Fisher, Joy, Desideri, Serena, Sims, Megan, Wen, Patrick, Grossman, Stuart
Foilsithe in Neuro Oncol (2018)

BIMG-12. [18F]FLUCICLOVINE PET TO DISTINGUISH PSEUDOPROGRESSION FROM TUMOR PROGRESSION IN POST-TREATMENT GLIOBLASTOMA

le Nabavizadeh, Ali, Doot, Robert, Young, Anthony, Nasrallah, MacLean, Ware, Jeffrey, Schubert, Erin, Henderson, Fraser, Pantel, Austin, Desai, Arati, Bagley, Stephen, O’Rourke, Donald, Brem, Steven
Foilsithe in Neurooncol Adv (2021)

Three‐dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma

le Verma, Gaurav, Chawla, Sanjeev, Mohan, Suyash, Wang, Sumei, Nasrallah, MacLean, Sheriff, Sulaiman, Desai, Arati, Brem, Steven, O'Rourke, Donald M., Wolf, Ronald L., Maudsley, Andrew A., Poptani, Harish
Foilsithe in NMR Biomed (2018)